Stay updated on Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial
Sign up to get notified when there's something new on the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page.
Latest updates to the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page
- Check7 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check57 days agoChange DetectedSeveral key genetic and health-related links have been removed from the website, including those related to lung and breast cancer, while a new 'Show less' feature has been added.SummaryDifference5%
- Check64 days agoChange DetectedNew resources related to genetics and cancer, including specific pages for lung and breast cancer, have been added to MedlinePlus and related NIH sites.SummaryDifference0.6%
- Check72 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.SummaryDifference5%
Stay in the know with updates to Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antibody Drug Conjugate in Advanced Breast Cancer HER2 Clinical Trial page.